About DK Biopharma
DK Biopharma is a Healthcare company based in Mumbai (India) founded in 2018. It specializes as a CDMO focused on manufacturing high-quality recombinant proteins. It operates on a B2B model. The company has 51 employees. Its Indian entity D.K. Biopharma Private Limited reported revenue of ₹8.14 Cr. Its focus areas include Biopharmaceuticals, Contract Manufacturing and Recombinant Proteins. Its competitors include Shantani Proteome Analytics and GeNext Genomics; 1 of its 2 listed competitors has raised funding.
Company details
DK Biopharma, based in Mumbai, focuses on providing healthcare solutions, biopharmaceuticals, contract manufacturing, and recombinant proteins. Specializes as a CDMO focused on manufacturing high-quality recombinant proteins. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
- Headquarters Mumbai, India
- Employees 51
- SectorsHealthcare
- Email••••••••
- Website dkbiopharma.com
- Legal Name D.K. Biopharma Private Limited
- Date of Incorporation 05 Jul, 2018
- Jurisdiction Ambernath, Maharashtra, India
- Annual Revenue₹8.14 Cr
FY 2025 · +13% YoY
- Net Loss-₹4.66 Cr
FY 2025 · -57% margin
- EBITDA₹2.31 Cr
FY 2025 · 28% margin
- Employee Count51
Associated legal entities of DK Biopharma
DK Biopharma operates through D.K. Biopharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| D.K. Biopharma Private Limited CIN U36100MH2018PTC311589 | Active | 05 Jul 2018 | Ambernath, Maharashtra | ₹8.1 Cr | 51 | 4 | View details |
Board of directors of D.K. Biopharma Private Limited (DK Biopharma)
D.K. Biopharma Private Limited is the primary company behind DK Biopharma. The board of D.K. Biopharma Private Limited currently have 4 directors; the longest-serving is Rakesh Kasturilal Bakshi, appointed in 2018. 2 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Rakesh Kasturilal Bakshi DIN 01816757 | Director | 05 Jul 2018 | 8 yrs 3 mo | D.K. Biopharma Private Limited |
| Alka Rakesh Bakshi DIN 08173871 | Director | 05 Jul 2018 | 8 yrs 3 mo | D.K. Biopharma Private Limited |
| Karan Rakesh Bakshi DIN 02470601 | Director | 04 Oct 2018 | 8 yrs | D.K. Biopharma Private Limited |
| Ajit Hari Behere DIN 02256156 | Director | 25 Nov 2019 | 6 yrs 11 mo | D.K. Biopharma Private Limited |
Financials of DK Biopharma
Figures of D.K. Biopharma Private Limited, the primary company behind DK Biopharma, for FY 2025. Revenue was ₹8.14 Cr (+13% year on year). Net loss was -₹4.66 Cr (-57% margin). EBITDA was ₹2.31 Cr (28% margin). Revenue has grown at a compounded annual rate of -14% over three years and -1% over five years.
- ₹8.14 CrRevenue · FY 2025 · +13% YoY
- -₹4.66 CrNet loss · -57% margin
- ₹2.31 CrEBITDA · 28% margin
- ₹25 LakhPaid-up capital
- 51Employees (provident fund records)
- -14%Revenue CAGR, 3 years
- -1%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of D.K. Biopharma Private Limited are on its company page.
Detailed financial statements for DK Biopharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of DK Biopharma
DK Biopharma has 2 listed competitors in our database, 1 of them funded. They include Shantani Proteome Analytics and GeNext Genomics.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| shantani.com | 2010 | Pune, India | $987,612 | Drug discovery services are delivered via chemical-proteomics technologies. | ||
| genextgenomics.com | 2011 | Nagpur, India | Recombinant proteins and monoclonal antibodies are developed for life sciences. |
Detailed competitors of DK Biopharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Biopharma Outsourcing & Drug Delivery
3 companies that operate in the same segment as DK Biopharma (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Developer of integrated contract research development and manufacturing services | 2007 | Bengaluru, Karnataka, India | USD 35.74 M | USD 226.38 M | 1,820 | |
Pharmaceutical and biotechnology company | 2005 | Hyderabad, Telangana, India | USD 229.73 M | USD 726.15 M | 12,470 | |
India's leading healthcare products distribution platform | 2018 | Mumbai, Maharashtra, India | USD 59.67 M | USD 702.49 M | 4,260 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about DK Biopharma
DK Biopharma was founded in 2018.
DK Biopharma is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
DK Biopharma has 51 employees.
The primary company behind DK Biopharma, D.K. Biopharma Private Limited, reported revenue of ₹8.14 Cr for FY 2025, up 13% year on year.
DK Biopharma, based in Mumbai, focuses on providing healthcare solutions, biopharmaceuticals, contract manufacturing, and recombinant proteins. Specializes as a CDMO focused on manufacturing high-quality recombinant proteins. The company prioritizes operational excellence, innovation, and customer-centric approaches for success. It continues to evolve, meeting industry challenges with strategic approaches.
DK Biopharma's top competitors include Shantani Proteome Analytics and GeNext Genomics.
DK Biopharma operates through D.K. Biopharma Private Limited.
The legal entities of DK Biopharma currently have 4 directors, including Rakesh Kasturilal Bakshi, Alka Rakesh Bakshi, Karan Rakesh Bakshi and others.